| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.009 | 0.8 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | 0.0087 | 0.8 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | 0.0096 | 0.8 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | -0.0083 | 0.8 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.015 | 0.8 |